Alexion and Moderna have an exclusive strategic agreement for the discovery and development of messenger RNA Therapeutics™ for rare diseases.

learn more

Moderna announces a landmark publication describing the first-ever protein production through messenger RNA therapeutics™.

learn more

Moderna and AstraZeneca have a strategic option agreement to develop up to forty messenger RNA Therapeutics™ for the treatment of serious cardiometabolic diseases and cancer.

learn more

We are delivering the next wave of innovation to treat serious illness.

here's how

We’ve assembled a team of scientists and drug hunters, executives and visionaries. Our experience is matched only by our passion.

get to know us


What's New

March 6, 2014

Moderna appoints biotechnology investment banking veteran Lorence Kim as Chief Financial Officer | Read more

February 19, 2014

Massachusetts Life Sciences Center awards tax incentive to Moderna Therapeutics | Read more

January 14, 2014

Moderna spins-out Onkaido Therapeutics to focus on the development of messenger RNA Therapeutics™ in oncology | Read more